Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · IEX Real-Time Price · USD
3.020
+0.010 (0.33%)
At close: Jul 2, 2024, 4:00 PM
3.080
+0.060 (1.99%)
After-hours: Jul 2, 2024, 7:09 PM EDT
Poseida Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for PSTX stock have an average target of 14.67, with a low estimate of 10 and a high estimate of 20. The average target predicts an increase of 385.76% from the current stock price of 3.02.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 22, 2024.
Analyst Ratings
The average analyst rating for PSTX stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +562.25% | May 22, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +562.25% | May 2, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +562.25% | Apr 22, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +562.25% | Mar 8, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +231.13% | Dec 11, 2023 |
Financial Forecast
Revenue This Year
75.87M
from 64.70M
Increased by 17.26%
Revenue Next Year
39.10M
from 75.87M
Decreased by -48.46%
EPS This Year
-1.47
from -1.37
EPS Next Year
-1.82
from -1.47
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 88.6M | 73.5M | 46.2M | 133.4M | 398.4M |
Avg | 75.9M | 39.1M | 22.4M | 87.8M | 237.0M |
Low | 64.3M | 9.8M | n/a | 53.6M | 83.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 37.0% | -3.1% | 18.2% | 494.6% | 353.6% |
Avg | 17.3% | -48.5% | -42.6% | 291.3% | 169.9% |
Low | -0.6% | -87.1% | - | 138.9% | -4.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.24 | -1.33 | -0.93 | -1.22 | 0.29 |
Avg | -1.47 | -1.82 | -1.40 | -1.19 | -0.16 |
Low | -1.68 | -2.49 | -1.75 | -1.15 | -0.58 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.